HLA-C and neoplasm: Presenting tumor antigens to T cells is the second step of cancer-immunity cycle [44, 50] and our results revealed that in ANK2-MT LUAD, DCs and MHC molecules, two key participants in antigen-presenting [51, 52], were elevated.